From SQZ Biotech Adds $72M as Cell Therapy Investment Keeps Burning Hot:

SQZ

SQZ—

SQZ Biotechnologies squeezes cells to open their membrane, allowing a protein or other material to enter. Image courtesy of SQZ.

Underwriters and Partners

Xconomy Insight

Sponsored · Special Report
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future
Hyperinflation in rents is over
Hughes Marino

From Our Editors · Special Report
Xcelerating Life Sciences Philadelphia: Special Report
Becoming the Cell & Gene Therapy Hub

Sponsored · Video
The Importance of Early Planning for Biotechs & Engaging with a CRO for Molecule Development
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Medpace

Xconomy on Demand

We offer a number of ways to subscribe for free!